Loading
Loading
Acadia Pharmaceuticals ceo salary
Stephen R. Davis of ACADIA PHARMACEUTICALS INC (ACAD), received $14,028,139 ($14.0M) in total compensation for FY2022, up 43.2% from the prior year. Stock awards of $8,926,598 were the largest component. Figures come from ACADIA PHARMACEUTICALS INC's DEF 14A filed 1 May 2023 (accession 0000950170-23-015969).
Reported total from the latest DEF 14A pay table. Source filing (accession 0000950170-23-015969). These figures come from ACADIA PHARMACEUTICALS INC's DEF 14A filed 1 May 2023 (accession 0000950170-23-015969).
| Component | Amount |
|---|---|
| Salary | $822,316 |
| Stock awards | $8,926,598 |
| Option awards | $3,643,271 |
| Cash incentive | $615,810 |
| Other | $20,144 |
| Total | $14,028,139 |
FAQ
See also: ACAD ticker page